Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Cash from Financing Activities (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Cash from Financing Activities for 15 consecutive years, with -$937340.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 38.29% to -$937340.0 in Q4 2025 year-over-year; TTM through Nov 2025 was -$4.7 million, a 384.64% decrease, with the full-year FY2025 number at -$4.7 million, down 384.64% from a year prior.
  • Cash from Financing Activities was -$937340.0 for Q4 2025 at Cryo Cell International, up from -$3.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $8.7 million in Q3 2022 to a low of -$5.6 million in Q4 2022.
  • A 5-year average of -$536115.5 and a median of -$794625.0 in 2021 define the central range for Cash from Financing Activities.
  • Biggest YoY gain for Cash from Financing Activities was 1217.08% in 2022; the steepest drop was 1476.04% in 2022.
  • Cryo Cell International's Cash from Financing Activities stood at -$814250.0 in 2021, then plummeted by 583.58% to -$5.6 million in 2022, then soared by 72.32% to -$1.5 million in 2023, then soared by 56.0% to -$677821.0 in 2024, then tumbled by 38.29% to -$937340.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Cash from Financing Activities are -$937340.0 (Q4 2025), -$3.5 million (Q3 2025), and $710155.0 (Q2 2025).